| ← Back to Cover | |||||||||
| COST OF GOODS SOLD & OPERATING EXPENSES | |||||||||
| All costs driven by percentage-of-revenue assumptions | |||||||||
| Historical | Projected | ||||||||
| ($mm) | FY2023 | FY2024 | FY2025 | FY2026 | FY2027 | FY2028 | FY2029 | FY2030 | |
| REVENUE REFERENCE | |||||||||
| Total Revenue | 440 | 477 | 510 | 550 | 595 | 643 | 688 | 735 | |
| COST OF GOODS SOLD | |||||||||
| COGS (% of Revenue) | 58.0% | 57.5% | 57.0% | 56.5% | 56.0% | 55.5% | 55.0% | 54.5% | |
| Cost of Goods Sold | 255 | 274 | 291 | 311 | 333 | 357 | 378 | 401 | |
| Gross Profit | 185 | 203 | 219 | 239 | 262 | 286 | 310 | 334 | |
| Gross Margin (%) | 42.0% | 42.5% | 43.0% | 43.5% | 44.0% | 44.5% | 45.0% | 45.5% | |
| OPERATING EXPENSES | |||||||||
| SG&A (% of Revenue) | 18.0% | 17.5% | 17.0% | 16.5% | 16.0% | 15.5% | 15.0% | 14.8% | |
| Selling, General & Administrative | 79 | 83 | 87 | 91 | 95 | 100 | 103 | 109 | |
| R&D (% of Revenue) | 6.0% | 6.0% | 6.0% | 6.0% | 5.8% | 5.6% | 5.5% | 5.4% | |
| Research & Development | 26 | 29 | 31 | 33 | 35 | 36 | 38 | 40 | |
| Other OpEx (% of Revenue) | 2.0% | 2.0% | 2.0% | 1.8% | 1.8% | 1.7% | 1.6% | 1.5% | |
| Other Operating Expenses | 9 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | |
| Total Operating Expenses | 114 | 122 | 128 | 134 | 140 | 147 | 152 | 159 | |
| OpEx (% of Revenue) | 26.0% | 25.5% | 25.0% | 24.3% | 23.6% | 22.8% | 22.1% | 21.7% | |
| EBITDA | |||||||||
| EBITDA | 70 | 81 | 92 | 106 | 121 | 140 | 158 | 175 | |
| EBITDA Margin (%) | 16.0% | 17.0% | 18.0% | 19.2% | 20.4% | 21.7% | 22.9% | 23.8% | |
| EBITDA Growth (%) | 15.2% | 13.2% | 15.0% | 14.9% | 15.0% | 12.9% | 11.0% | ||
| Notes: | |||||||||
| - All cost items are driven by % of revenue assumptions from the Assumptions sheet | |||||||||
| - D&A is excluded from operating expenses here and shown separately in D&A Schedule | |||||||||